149 related articles for article (PubMed ID: 34118029)
21. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol.
Patel NR; Hatziantoniou S; Georgopoulos A; Demetzos C; Torchilin VP; Weissig V; D'Souza GG
J Liposome Res; 2010 Sep; 20(3):244-9. PubMed ID: 19883213
[TBL] [Abstract][Full Text] [Related]
22. Medicinal applications and molecular targets of dequalinium chloride.
Bailly C
Biochem Pharmacol; 2021 Apr; 186():114467. PubMed ID: 33577890
[TBL] [Abstract][Full Text] [Related]
23. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
24. Towards mitochondrial gene therapy: DQAsomes as a strategy.
Weissig V; Torchilin VP
J Drug Target; 2001; 9(1):1-13. PubMed ID: 11378519
[TBL] [Abstract][Full Text] [Related]
25. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
26. Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy.
Zhou W; Yu H; Zhang LJ; Wu B; Wang CX; Wang Q; Deng K; Zhuo RX; Huang SW
Nanoscale; 2017 Nov; 9(43):17044-17053. PubMed ID: 29083424
[TBL] [Abstract][Full Text] [Related]
27. Preparation and antitumor evaluation of hinokiflavone hybrid micelles with mitochondria targeted for lung adenocarcinoma treatment.
Chen Y; Feng X; Li L; Song K; Zhang L
Drug Deliv; 2020 Dec; 27(1):565-574. PubMed ID: 32252563
[TBL] [Abstract][Full Text] [Related]
28. Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems.
Weissig V; Torchilin VP
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):127-49. PubMed ID: 11377808
[TBL] [Abstract][Full Text] [Related]
29. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
30. From serendipity to mitochondria-targeted nanocarriers.
Weissig V
Pharm Res; 2011 Nov; 28(11):2657-68. PubMed ID: 21833792
[TBL] [Abstract][Full Text] [Related]
31. Interaction of dequalinium chloride with phosphatidylcholine bilayers: A biophysical study with consequences on the development of lipid-based mitochondrial nanomedicines.
Sauvage F; Legrand FX; Roux M; Rajkovic I; Weiss TM; Varga Z; Augis L; Nugue G; Debouzy JC; Vergnaud-Gauduchon J; Barratt G
J Colloid Interface Sci; 2019 Mar; 537():704-715. PubMed ID: 30497059
[TBL] [Abstract][Full Text] [Related]
32. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
[TBL] [Abstract][Full Text] [Related]
33. Power of mitochondrial drug delivery systems to produce innovative nanomedicines.
Yamada Y; Satrialdi ; Hibino M; Sasaki D; Abe J; Harashima H
Adv Drug Deliv Rev; 2020; 154-155():187-209. PubMed ID: 32987095
[TBL] [Abstract][Full Text] [Related]
34. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
35. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
36. A thermoresponsive nanocarrier for mitochondria-targeted drug delivery.
Wang D; Huang H; Zhou M; Lu H; Chen J; Chang YT; Gao J; Chai Z; Hu Y
Chem Commun (Camb); 2019 Apr; 55(28):4051-4054. PubMed ID: 30870553
[TBL] [Abstract][Full Text] [Related]
37. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
[TBL] [Abstract][Full Text] [Related]
38. ROS as a novel indicator to predict anticancer drug efficacy.
Zaidieh T; Smith JR; Ball KE; An Q
BMC Cancer; 2019 Dec; 19(1):1224. PubMed ID: 31842863
[TBL] [Abstract][Full Text] [Related]
39. Targeting drugs to mitochondria.
Heller A; Brockhoff G; Goepferich A
Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
[TBL] [Abstract][Full Text] [Related]
40. [Changes in mitochondrial function induced by dequalinium precede oxidative stress and apoptosis in the human prostate cancer cell line PC-3].
Makowska K; Estan MC; Ganan-Gomez I; Boyano-Adanez MC; Garcia-Perez AI; Sancho P
Mol Biol (Mosk); 2014; 48(3):416-28. PubMed ID: 25831891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
